Pediatric & Prenatal Lead Cadmium Testing for Vulnerable Populations

1 / 5

Pediatric & Prenatal Lead Cadmium Testing for Vulnerable Populations

Customization:	Available
Classification:	Physiological Functions of Diagnosis and Monitoring Equipment
Type:	Trace Element Analyzer

Send Inquiry

Product Description

■

Basic Information

Certification

CE, ISO13485, Nmpa

Group

Full Range

Weight

45kg

Detection Limit

Pb≤4 Pg

Detection Deviation

≤10%

Real-Time Detection

1.5 Mins/Test

Interface

USB; HDMI; Ethernet

Repeatability

≤10%

Correlation

R≥0.995

Power Supply

220V, 50Hz

Operating Temp

(10-30)℃

Specification

782 mm×560mm×338 mm

■

Technology Overview

The trace element analyzer is designed to measure lead (Pb) and cadmium (Cd) levels in whole blood, breast milk, or urine. It employs atomic absorption spectrometry (AAS), using a graphite tube as a high-temperature atomizer, combined with self-absorption background correction technology to ensure accurate results.

■

AAS-S200 Specifications

Trace Element Analyzer AAS-S200 enables simultaneous detection of lead and cadmium. It consists of a light source system, graphite furnace atomization system, optical system, and an integrated processing system. It can be connected to an automatic autosampler for automated sample loading.

Sample Type: Whole blood, serum, urine, breast milk

Parameter	Detail
Model	AAS-S200
Detection method	Atomic spectrometry
Elements detected	Lead, Cadmium
Detection time	1.5 minutes per sample
Detection Limit	Pb≤4 pg
Detection Deviation	≤10%
Operating Humidity	≤70%

■

Key Features

✚

Broad Application: Supports measurement of multiple specimen types including whole blood, urine, and breast milk.

✚

Rapid Detection: Simultaneous quantification of lead and cadmium in a single sample within 1.5 minutes.

✚

Easy Operation: Integrated design with optional automatic autosampler for streamlined workflow.

✚

Enhanced Safety: Continuous monitoring of graphite furnace status with precise process control.

■

R&D and Industrialization

Our In Vitro Diagnosis unit boasts strong independent R&D capabilities, utilizing platforms such as molecular diagnosis, immunoassay, atomic absorption, and mass spectrometry. The human trace element detection system is widely utilized in over 4,000 medical institutions, handling millions of person-times annually. Our microfluidic technology, often called "laboratory on a chip," provides automated nucleic acid testing for diverse health organizations.